Nelson Travis J, Zhao Jia, Stains Cliff I
Department of Chemistry and Nebraska Center for Integrated Biomolecular Communication, University of Nebraska-Lincoln, Lincoln, NE, United States.
Department of Chemistry and Nebraska Center for Integrated Biomolecular Communication, University of Nebraska-Lincoln, Lincoln, NE, United States; Cancer Genes and Molecular Recognition Program, Fred & Pamela Buffet Cancer Center, University of Nebraska Medical Center, Omaha, NE, United States.
Methods Enzymol. 2019;622:55-66. doi: 10.1016/bs.mie.2019.02.003. Epub 2019 Mar 9.
Protein misfolding and aggregation is now recognized as a hallmark of numerous human diseases. Standard bioanalytical techniques for monitoring protein aggregation generally rely on small molecules that provide an optical readout of fibril formation. While these methods have been useful for mechanistic studies, additional approaches are required to probe the equilibrium between soluble and insoluble protein within living systems. Such approaches could provide platforms for the identification of inhibitors of protein aggregation as well as a means to investigate the effect of mutations on protein aggregation in model systems. In this chapter, we provide detailed protocols for employing split-NanoLuc luciferase (Nluc) fragments to monitor changes in protein solubility in bacterial and mammalian cells. This sensitive luminesce-based assay can report upon changes in protein solubility induced by inhibitors and disease-relevant mutations.
蛋白质错误折叠和聚集现在被认为是众多人类疾病的一个标志。用于监测蛋白质聚集的标准生物分析技术通常依赖于提供纤维形成光学读数的小分子。虽然这些方法对机理研究很有用,但还需要其他方法来探测生物系统中可溶性和不溶性蛋白质之间的平衡。这些方法可以为鉴定蛋白质聚集抑制剂提供平台,也可以作为一种手段来研究模型系统中突变对蛋白质聚集的影响。在本章中,我们提供了详细的方案,用于使用分裂纳米荧光素酶(Nluc)片段来监测细菌和哺乳动物细胞中蛋白质溶解度的变化。这种基于灵敏发光的检测方法可以报告由抑制剂和与疾病相关的突变引起的蛋白质溶解度变化。